He points out that with Enbrel and Humira, two drugs from Amgen (nasdaq: AMGN - news - people ) and Abbott Laboratories (nyse: ABT - news - people ) that are the most used treatments for rheumatoid arthritis (RA), many patients remain in serious pain.
FORBES: Genentech's Next Act